Abebe W, Harris K H, MacLeod K M
Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.
Can J Physiol Pharmacol. 1994 Dec;72(12):1544-51. doi: 10.1139/y94-222.
Maximum contractile responses of diabetic aortas incubated in the absence of extracellular Ca2+ to increasing Ca2+ (0.01-10 mM) in the presence of 1 microM noradrenaline, but not 40 mM KCl, were significantly increased compared with those of age-matched control rats. Maximum contractile responses of both aortas and mesenteric arteries from diabetic rats to noradrenaline, but not KCl, in the presence of extracellular Ca2+ (2.5 mM) were also significantly enhanced. The Ca2+ channel antagonists verapamil and nifedipine and the Ca2+ channel agonist BAY K8644 produced a similar percentage change in the magnitude of the noradrenaline response in arteries from both control and diabetic rats. These data confirm the selective nature of the enhancement of contractile responses of arteries from diabetic rats to noradrenaline and suggest that this may be mediated in part through enhanced noradrenaline-induced influx of extracellular Ca2+ through channels sensitive to the Ca2+ channel ligands. However, this does not appear to be the only explanation for the enhanced contractile responses of diabetic arteries to noradrenaline, since in the presence of maximum concentrations of nifedipine (3 microM) and verapamil (10 microM), responses of diabetic arteries to noradrenaline were still greater than those of control arteries.
在无细胞外Ca2+的情况下孵育的糖尿病大鼠主动脉,在存在1微摩尔去甲肾上腺素而非40毫摩尔氯化钾时,对增加的Ca2+(0.01 - 10毫摩尔)的最大收缩反应与年龄匹配的对照大鼠相比显著增加。糖尿病大鼠的主动脉和肠系膜动脉在细胞外Ca2+(2.5毫摩尔)存在时对去甲肾上腺素而非氯化钾的最大收缩反应也显著增强。Ca2+通道拮抗剂维拉帕米和硝苯地平以及Ca2+通道激动剂BAY K8644在对照和糖尿病大鼠的动脉中对去甲肾上腺素反应幅度产生的百分比变化相似。这些数据证实了糖尿病大鼠动脉对去甲肾上腺素收缩反应增强的选择性,并表明这可能部分通过增强去甲肾上腺素诱导的细胞外Ca2+通过对Ca2+通道配体敏感的通道内流来介导。然而,这似乎并不是糖尿病动脉对去甲肾上腺素收缩反应增强的唯一解释,因为在存在最大浓度的硝苯地平(3微摩尔)和维拉帕米(10微摩尔)时,糖尿病动脉对去甲肾上腺素的反应仍大于对照动脉。